These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39025435)

  • 1. Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration.
    Keenan TDL; Agrón E; Keane PA; Domalpally A; Chew EY; ;
    Ophthalmology; 2025 Jan; 132(1):14-29. PubMed ID: 39025435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol Consumption and Risk of Age-Related Macular Degeneration and Geographic Atrophy Progression: Age-Related Eye Diseases Study 2 Report 34.
    Duic C; Vance E; Agrón E; Keenan TDL;
    Ophthalmol Retina; 2024 Nov; ():. PubMed ID: 39547357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 Trials.
    Danzig CJ; Khanani AM; Kaiser PK; Chang MA; Kovach JL; Lally DR; Rachitskaya A; Sheth VS; Vajzovic L; Clark J; Tang J; Zhu L; Desai D; Chakravarthy U
    Ophthalmol Retina; 2024 Nov; 8(11):1052-1060. PubMed ID: 38719191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
    Evans JR; Lawrenson JG
    Cochrane Database Syst Rev; 2023 Sep; 9(9):CD000254. PubMed ID: 37702300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    Age-Related Eye Disease Study 2 Research Group
    JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
    van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
    Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME; MacDonald JK; Griffiths AM; Steinhart AH; Seow CH
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007698. PubMed ID: 26497719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
    ; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
    JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Macular Choriocapillaris Perfusion Correlates with Contrast Sensitivity Function in Dry Age-Related Macular Degeneration.
    Romano F; Vingopoulos F; Yuan M; Ding X; Garcia M; Ploumi I; Rodriguez J; Garg I; Tracy JH; Bannerman A; Choi H; Stettler I; Bennett C; Overbey KM; Laìns I; Kim LA; Vavvas DG; Husain D; Miller JW; Miller JB
    Ophthalmol Retina; 2024 Dec; 8(12):1140-1150. PubMed ID: 38878897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40.
    Jhaveri CD; Liu D; Maguire MG; Glassman AR; Grigorian RA; Jampol LM; Kingsley RM; MacCumber MW; Martin DF; Maturi RK; Velez G; Sun JK;
    Ophthalmology; 2024 Aug; 131(8):967-974. PubMed ID: 38336282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supplemental Intravitreal Ranibizumab Injections in Eyes Treated with the Port Delivery System with Ranibizumab in the Archway Trial.
    Nielsen JS; Chang A; Holekamp NM; Cavichini-Cordeiro M; Lin SL; Heinrich D; Maass KF; Menezes A; Singh N; Pieramici DJ
    Ophthalmol Retina; 2024 Dec; 8(12):1127-1139. PubMed ID: 38914294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone Preservation.
    Ehlers JP; Hu A; Boyer D; Cousins SW; Waheed NK; Rosenfeld PJ; Brown D; Kaiser PK; Abbruscato A; Gao G; Heier J;
    Ophthalmol Sci; 2025; 5(1):100628. PubMed ID: 39605874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of nutritional factors in transitioning between early, mid, and late stages of age-related macular degeneration: prospective longitudinal analysis.
    Seddon JM; De D; Rosner B
    Am J Clin Nutr; 2024 Dec; 120(6):1387-1398. PubMed ID: 39181206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD007807. PubMed ID: 28752910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes.
    Aggarwal S; Moir J; Hyman MJ; Kaufmann GT; Flores A; Hariprasad SM; Skondra D
    JAMA Ophthalmol; 2024 Jan; 142(1):53-57. PubMed ID: 38019527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for treating lymphocytic colitis.
    Chande N; Al Yatama N; Bhanji T; Nguyen TM; McDonald JW; MacDonald JK
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006096. PubMed ID: 28702956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen for adults with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.
    Lim AWY; Schneider L; Loy C
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD001747. PubMed ID: 39498781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
    ; Chew EY; Clemons T; SanGiovanni JP; Danis R; Domalpally A; McBee W; Sperduto R; Ferris FL
    Ophthalmology; 2012 Nov; 119(11):2282-9. PubMed ID: 22840421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.